A women speaks in front of a wall-mounted television displaying a slide from Resuture

Mayo Clinic and ASU MedTech Accelerator’s Fifth Cohort Indicative of the Coming AI-Wave in Healthcare

Published: 03/06/2024

Mayo Clinic, ASU announce new MedTech Accelerator Cohort

PHOENIX (March 6, 2024) — Mayo Clinic in Arizona and Arizona State University (ASU) are kicking off the fifth cohort of the MedTech Accelerator on March 17, 2024. The Accelerator brings together leaders in innovation from across the globe and healthcare industry to advance their products, knowledge and value propositions in one of the nation’s fastest-growing biomedical hubs — Arizona.

The Accelerator provides emerging companies with a multi-day immersive curriculum in health care entrepreneurship including: lectures and workshops with world-class scientific and engineering experts; resources to navigate regulatory pathways; and tools for product commercialization and customer acquisition. Additionally, participants attend mentoring, business development, and networking events.

“One of the most rewarding aspects of our Accelerator program is the hands-on experience our students receive,” said Dr. Rick Hall, co-managing partner of the MedTech Accelerator and ASU emeritus professor.  “This year we will have representation from our National Science Foundation Research Traineeship interning with the program. These students, whose graduate work is focused on the design and manufacturing of medical devices, will obtain a level of hands-on experience rarely offered at this level of study.”

After the two-week curriculum portion of the program, the cohort will remain a part of the MedTech Accelerator support network allowing continued collaboration and guidance.

“Now that we are in our fifth cohort of the Accelerator we have a bit of history to look back on and can see how the Accelerator acts as an indicator of sea-change in the MedTech industry,” said Steven Lester, M.D., medical director for Mayo Clinic’s Discovery Oasis and co-founder and chief medical officer of the MedTech Accelerator. “Just last year we identified that AI was about to become a key focus in the medical innovation space and this year nearly a third of our cohort companies have AI at the center of their product design.”

Arizona’s reputation as a medical destination and biotech ecosystem continues to rise. Most recently, ASU and Mayo Clinic received grant monies from the Flinn Foundation to fund a new inter-institutional Division of Medical Engineering to develop a best-in-class learning and innovation ecosystem where faculty, clinical staff, and students collaborate to solve real-world clinical problems.

“The diversity of this cohort is representative of the deep collection of medtech capabilities being developed around Greater Phoenix,” said Greater Phoenix Economic Council President & CEO Chris Camacho. “It’s invigorating to see how this accelerator is changing the market and providing these companies opportunities to develop their products and truly make a difference in the sphere. We’re seeing the future of medical care develop before our eyes.”

This year’s participating companies span a wide range of solutions across wellness, health care and medicine:

Aavia, New York

Aavia is an app that empowers patients to track 30+ physical, mental, and emotional hormone health indicators for detailed monitoring and heightened self-awareness. This enables precise daily symptom prediction for a personalized, scientifically informed experience. The use of Aavia by patients gives healthcare providers comprehensive and real-time data about their patients’ hormone health, enabling prompt and informed care responses.

Brain Navi, Taiwan

Brain Navi is an innovative medical device company with a particular focus on surgical robotic systems. Besides the flagship neurosurgical navigation robot NaoTrac, the company’s product pipeline includes KrystoLens (a single-use neuro-endoscope) and another surgical robot in the R&D stage which is yet to be announced.

Galileo Group, Florida

Galileo has performed approved pre-clinical research and collected hundreds of live patient on-site scans to develop a science-grade database, detection algorithms and skin response models. Specialized capabilities and resources are in continued development and include: human tissue spectral signatures with reference pathology, skin surface imaging for lesion detection, skin cancer mapping and skin radiation effects measurement, sub-surface vascular imaging, and multi-sensor measurement and data fusion for 3D body mapping.

JelloX, Taiwan

JelloX, is at the forefront of innovation in the pathology space. Its patented 3D digital pathology tissue imaging with AI-empowered analysis translates into a precision diagnosis solution. The aim is to create the world’s first 3D digital pathology solution in support of precision cancer diagnosis, optimize patient treatment outcome, and match the right patients with the right drugs at the right time.

MiiCare, United Kingdom

The MiiCare team believes everyone should be able to live the life they choose from the comfort of home and not have to worry about their health as they age. To power this independent lifestyle, a preventative care platform collects and converts comprehensive sensor data into actionable wisdom for providers to personalize effective care plans at scale. Monica, a conversational AI health coach, then supports older adults to self-care at home in an empowering aging experience that extends life span.

Mindsigns Health, Singapore

Mindsigns Health™ is a global provider of an AI powered platform to monitor brain disorders and mental illnesses. Mindsigns Health™ develops secure healthcare products that meet the needs of both clinicians and patients to improve the patient journey and empower the doctor-patient relationship.

NeuroBrowser™ is an automated EEG analysis software to interpret and analyze electrical abnormalities in neurological disorders such as epilepsy and the monitoring of patients in clinical and ambulatory environments.

GenMind™ captures audio and other digital signals outside clinical and office settings to enable the remote monitoring of negative symptoms and cognitive impairment, which are biomarkers associated with a number of serious mental illnesses, in order to deliver a continuum of care, improve access and help increase compliance.

NurseIO, Arizona

NurseIO is an app-based technology platform that connects health care professionals looking for flexible work to open per diem shifts within their local vicinity. NurseIO provides clinicians a path to follow their passion of taking care of patients on their own terms and in turn, we provide healthcare facilities vetted, qualified and experienced clinicians to fill gaps when needed.

Paldara Pharmaceuticals, Oklahoma

Paldara is developing the next generation of antimicrobial medical device coatings. A primary indication is as a hydrogel coating for urinary catheters in order to prevent up to 99% of catheter-associated urinary tract infections (CAUTIs), the most common hospital acquired infection.

Roddy Medical, Wisconsin

Roddy Medical’s SecureMove-TLC® is a single-patient use medical device designed to secure and manage different types of medical tubes, lines and cords to support patient therapy efficiency and improve medical line management and safety. The tension mitigation device is designed to eliminate hazardous pulling and line/cord dislodgement during therapy, transport, and patient movement, unlike any existing products, providing hospital cost savings.

Scaled Insights, Ontario, Canada

Scaled Insights is a developer of behavioral artificial Intelligence software designed to understand human behavior and help doctors to nudge their patients toward healthier pathways. The company’s software reduces a small sample of the human language down to personality profiles that include multiple variables (based on the big five personality attributes), and then used to cluster people into Personas groups, enabling us to build models to determine how to nudge people in each unique personality group in order to influence healthy behavior choices.

Learn more about the Mayo and ASU MedTech Accelerator.

About MedTech Accelerator

The MedTech Accelerator is supported by The Mayo Clinic and Arizona State University Alliance for Health Care. The alliance is developing comprehensive improvements in the science of health care delivery and practice, all toward one goal: continually advancing patient care. Together, the recognized world leader in patient care, education and research, and the nation’s No. 1-ranked university for innovation are combining expertise from every corner of health care — doctors to bioengineers to business experts — for an adaptive approach to preparing the next generation of health care pioneers and practitioners in our communities.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.

About Arizona State University

Arizona State University has developed a new model for the American Research University, creating an institution that is committed to access, excellence and impact. ASU measures itself by those it includes, not by those it excludes. As the prototype for a New American University, ASU pursues research that contributes to the public good, and ASU assumes major responsibility for the economic, social and cultural vitality of the communities that surround it.

 Media contacts:

Annie DeGraw, Strategic Communications Manager, Arizona State University
Phone: (602) 502-3856
Email: annie.degraw@asu.edu

Jennifer Ruble, Communications, Mayo Clinic
Phone: (507) 284-5005
Email: ruble.jennifer@mayo.com